TMAN.BK T Man Pharmaceutical PCL

Healthcare Drug Manufacturers - Specialty & Generic Thailand Exchange
10.20 THB
Close of Nov 7, 2026
9.47 12.95
Market cap
THB 4.08B
P/E
8.0x
P/B
1.85x
ROE
19.3%
Dividend yield
4.31%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is TMAN.BK undervalued?

Graham number
Price10.20
Graham value12.54
Discount18.7%

TMAN.BK trades 18.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

T Man Pharmaceutical PCL fundamental analysis

No fundamental analysis for T Man Pharmaceutical PCL yet.

T Man Pharmaceutical PCL stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About T Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatolog…

Full company profile